Fluctuations of serum fibroblast growth factor-21 levels in prolonged fasting in male adults

被引:0
|
作者
Agacdiken, Aslihan [1 ]
Goktas, Zeynep [1 ,2 ]
机构
[1] Hacettepe Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkiye
[2] Hacettepe Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-06100 Ankara, Turkiye
关键词
Adaptation to fasting; Body composition; Fibroblast growth factor -21; Nutritional status; Prolonged fasting; PPAR-ALPHA; BODY-COMPOSITION; RAMADAN; WEIGHT; FGF21; TIME; FAT;
D O I
10.1016/j.clnesp.2023.06.024
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Fibroblast Growth Factor-21 (FGF21) is a significant protein in the process of adaptation to fasting. The aim of this cross-sectional study to examine the effects of fasting on serum FGF21 levels, nutritional status, and anthropometric measurements of adult males during prolonged Ramadan fasting.Methods: This study included a total of 12 healthy individuals with normal body mass index, between the ages of 18-35. All individuals fasted for 16 h each day for 29 days of Ramadan. A questionnaire was administered to determine individuals' general characteristics and nutritional habits. Anthropometric measurements, 24-h dietary recall, and physical activities were recorded, and blood samples were collected four times in the following periods: before Ramadan, 1st week of Ramadan, 3rd week of Ramadan and 4 weeks after Ramadan. Results: It was observed that serum FGF21 levels increased until the 1st week of fasting. Remarkably, FGF21 levels declined in most subjects during the late phase of fasting and continued to decrease until 4 weeks after fasting. There was a positive correlation between serum FGF21 levels and protein intake at the 3rd week of fasting. Individuals' PAL and energy expenditure increased during fasting and continued to increase until 4 weeks after fasting. Energy intake, on the other hand, decreased from baseline until 4 weeks after fasting.Conclusion: FGF21 serum levels may show an increase during fasting, however in long-term fasting periods like Ramadan it may decrease back to the beginning levels, therefore, FGF21 serum levels must be evaluated carefully.& COPY; 2023 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 50 条
  • [21] Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis
    Hao Liu
    Xia He
    Xiao-Yan Deng
    Jing-Lu Yan
    BMC Musculoskeletal Disorders, 24
  • [22] Serum Levels of Fibroblast Growth Factor 21 Are Elevated in Both Rodents and Humans in Response to Acute Fasting
    Xia, Fuzhen
    Lam, Karen S. L.
    Zhang, Jialiang
    Zhou, Pengcheng
    Xu, Aimin
    DIABETES, 2010, 59 : A438 - A438
  • [23] Effects of aerobic versus resistance training on serum fetuin-A, fetuin-B, and fibroblast growth factor-21 levels in male diabetic patients
    Keihanian, A.
    Arazi, H.
    Kargarfard, M.
    PHYSIOLOGY INTERNATIONAL, 2019, 106 (01) : 70 - 80
  • [24] Exploring the correlation between serum fibroblast growth factor-21 levels and Sarcopenia: a systematic review and meta-analysis
    Liu, Hao
    He, Xia
    Deng, Xiao-Yan
    Yan, Jing-Lu
    BMC MUSCULOSKELETAL DISORDERS, 2023, 24 (01)
  • [25] Fibroblast growth factor-21 attenuates olanzapine induced hyperglycemia
    Jeromson, Stewart
    Medak, Kyle
    Bellucci, Annalaura
    Arbeau, Meagan
    Wright, David
    PHYSIOLOGY, 2023, 38
  • [26] Fibroblast Growth Factor-21 Is a Promising Dietary Restriction Mimetic
    Mendelsohn, Andrew R.
    Larrick, James W.
    REJUVENATION RESEARCH, 2012, 15 (06) : 624 - 628
  • [27] Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
    Kharitonenkov, Alexei
    Shanafelt, Armen B.
    BIODRUGS, 2008, 22 (01) : 37 - 44
  • [28] Fibroblast growth factor-21: a metabolic regulator or something more?
    Salgado, Joao Victor
    Salgado, Bernardete Jorge
    CLINICAL ENDOCRINOLOGY, 2014, 81 (06) : 938 - 940
  • [29] Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
    Alexei Kharitonenkov
    Armen B. Shanafelt
    BioDrugs, 2008, 22 : 37 - 44
  • [30] Pioglitazone Decreases Plasma Fibroblast Growth Factor-21 Levels in Patients with Type 2 Diabetes
    Mawatari, Kazutoshi
    Tahara, Nobuhiro
    Yasukawa, Hideo
    Oba, Toyoharu
    Nagata, Takanobu
    Kyogoku, Sachiko
    Ohshima, Hideki
    Minami, Tomoko
    Mizoguchi, Minori
    Sugi, Yusuke
    Adachi, Hisashi
    Imaizumi, Tsutomu
    CIRCULATION, 2012, 126 (21)